Clare Rawlinson-Malone
Executive Director, Site Lead and Head of Regulated Analytical Science and Operations. Bristol Myers Squibb (BMS)
Her career spans academia, healthcare and industry, giving her a broad perspective on the UK science and skills landscape and the interfaces between education, research and industrial application. She joined BMS in 2011 after a period as a university lecturer in Pharmacy Practice and Pharmaceutics, where she contributed to the development of accredited, award-winning undergraduate Pharmacy curricula. She has since progressed through senior scientific and leadership roles, combining expertise in formulation and analytical science with organisational responsibility.
At Moreton, Clare leads a multidisciplinary team of over 250 colleagues delivering the design, development and supply of medicines worldwide. Her remit spans regulated analytical science, quality systems and operational infrastructure, ensuring innovation is translated into robust, compliant and scalable delivery. She brings extensive experience in regulated environments, including GMP testing, method validation, stability programmes and inspection readiness, underpinning strong governance and risk management.
A key focus of Clare’s leadership is the development of future-ready scientific capability in the UK. Working with the Royal Society of Chemistry, ABPI and UK Government think tanks, she has championed apprenticeship and early career pathways that widen access to science while addressing critical skills gaps. This is complemented by her support for talent development through organisations such as the Analytical Science Network, Analytical Chemistry Trust Fund, RSC North West Analytical Division and the Academy of Pharmaceutical Scientists. Her contribution to BMS training and skills programmes reflects a strong commitment to social mobility, diversity and the long-term sustainability of the UK and global talent pipeline.
Clare is a strong advocate for the role of UK-based science within the BMS global organisation. Under her leadership, the Moreton site has expanded its capability and impact, supporting the development of complex medicines, enabled by strong links with universities, regional partners and national stakeholders. This includes multidisciplinary academic collaborations across chemistry, digital and engineering to accelerate innovation.
She is recognised for connecting scientific excellence with inclusive, people-centred leadership, fostering collaboration, continuous improvement and high-performing teams. This approach has been acknowledged through external recognition, including a UK-wide Business of Science Leadership Award.
Clare also brings experience in embedding sustainable, responsible innovation into scientific operations. At Moreton, this is demonstrated through advanced laboratory design, green chemistry and local supply chain engagement delivering environmental and economic value, recognised through a Bionow Sustainability Award.
She holds an MPharm and a PhD in Pharmaceutics and Analytical Characterisation, alongside a postgraduate Master’s qualification in academic practice. Outside work, she enjoys singing, dancing, theatre and spending time outdoors with her two girls.
Clare brings to board roles a combination of scientific depth, operational leadership and a strong interest in the systems underpinning UK science and industry, from workforce development and skills pipelines to innovation ecosystems and regional growth. She is motivated by opportunities to align skills, innovation and performance to ensure the UK remains globally competitive in life sciences and advanced manufacturing.